[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Conditions](https://durgical.com/en/conditions/) › Tuberculosis diagnostics

# Tuberculosis diagnostics

How TB is proven: which test finds the bacillus fastest, which shows the drugs that will work, and how Colombia decides who gets tested.

Updated Nov 19, 2026

On this page

- The basics What it is
- How to think about it
- Who gets it
- Causes
- Risk factors
- Pathophysiology
- Classification
- Which TB test does what
- Common traps
- Why it happens

- Clinical Symptoms and signs
- Diagnosis
- Differential diagnosis
- Complications
- Prognosis

- Treatment Goal of treatment
- Treatment
- Prevention

- Study Test yourself

- Connections Connections

## What it is

The set of tests used to diagnose active [tuberculosis](https://durgical.com/en/conditions/tuberculosis/) and its drug resistance: rapid molecular tests (such as Xpert MTB/RIF Ultra), sputum smear microscopy, mycobacterial culture, urine LAM in people with HIV, drug-susceptibility testing and chest imaging, organised in Colombia by the national programme's diagnostic algorithms.

## How to think about it

Every TB work-up answers three questions in order: Is it TB? Which drugs will work? Where is it? A rapid molecular test answers the first two from one sputum in about two hours, which is why it now comes first; culture is slower but remains the reference that confirms and tests every drug; imaging shows where the disease is but never proves it is TB.

See it in 3D

- [Right upper lobe](https://durgical.com/en/anatomy/superior-lobe-of-right-lung/)
- [Left upper lobe](https://durgical.com/en/anatomy/superior-lobe-of-left-lung/)
- [Mediastinal lymph nodes](https://durgical.com/en/anatomy/mediastinal-lymph-nodes/)
- [Pleura](https://durgical.com/en/anatomy/pleura/)

## Who gets it

Colombia reports more than 14,000 TB cases a year. Its programme (Resolución 227 de 2020) set out algorithms for the general population, vulnerable groups, people with HIV or immune suppression and children under 15, and the Instituto Nacional de Salud states that from 2022 rapid molecular tests replace smear microscopy as the first test for every respiratory symptomatic.

## Causes

- Target: [Mycobacterium tuberculosis](https://durgical.com/en/microbiology/mycobacterium-tuberculosis/) complex, a slow-growing acid-fast bacillus
- Samples: sputum (spontaneous or induced), gastric aspirate or induced sputum in children, bronchoalveolar lavage, fluids, tissue biopsies and urine

## Risk factors

- Who gets tested in Colombia: the respiratory symptomatic (sintomático respiratorio), a person with cough and expectoration for more than 15 days
- People with HIV: any cough, fever, weight loss or night sweats of any duration
- Children under 15: cough for 15 days or more, fever for more than 8 days, less activity or play, weight loss or poor gain, or contact with a TB case
- Groups that go straight to molecular testing plus liquid culture: prisoners, [homeless people](https://durgical.com/en/nursing/people-who-live-on-the-street-health-risks-and-how-to-reach-them/), migrants from high-burden countries, health workers, contacts of drug-resistant cases and others listed by the programme

## Pathophysiology

Each test sees a different trace of the bacillus → smear sees whole acid-fast bacilli and needs thousands per millilitre, so it misses paucibacillary disease → molecular tests amplify bacterial DNA and detect far fewer organisms, plus the rpoB mutations that cause [rifampicin](https://durgical.com/en/pharmacology/rifampicin/) resistance → culture grows live bacilli from as few as tens per millilitre, which allows species identification and testing of every drug, but takes weeks → urine LAM detects a cell-wall sugar shed by bacilli and is most positive when immunity is worst → imaging shows the tissue reaction, which other infections and cancer can copy.

## Classification

- Bacteriologically confirmed TB: positive smear, culture or WHO-recommended rapid test
- Clinically diagnosed TB: treated on clinical and radiological grounds without bacteriological confirmation
- Drug-susceptible, rifampicin-resistant (RR), multidrug-resistant (MDR: [isoniazid](https://durgical.com/en/pharmacology/isoniazid/) and rifampicin) and pre-extensively or extensively drug-resistant

## Symptoms and signs

- Cough with expectoration for more than 15 days (the trigger for testing in Colombia)
- Fever, night sweats, weight loss and fatigue
- [Haemoptysis](https://durgical.com/en/conditions/haemoptysis/) and chest pain
- In people with HIV, any of cough, fever, weight loss or night sweats, whatever the duration

## Diagnosis

**Clinical**
Think TB in every respiratory symptomatic and in anyone with HIV and one of the four symptoms. Collect a good [sputum sample](https://durgical.com/en/nursing/specimen-collection-urine-stool-sputum-and-swabs/) (early morning is best; induced sputum, gastric aspirate or lavage when there is none). If tests are negative but suspicion stays high, check sample quality, repeat samples and consider other diagnoses before treating clinically.

**Tests**
Rapid molecular test (Xpert MTB/RIF Ultra and similar): detects M. tuberculosis and rifampicin resistance in about two hours; first-line test. Smear microscopy (Ziehl–Neelsen or fluorescent): cheap and fast but insensitive; still used to follow treatment response. Culture, preferably in liquid medium (results in 1–3 weeks versus 3–8 on solid medium): the [reference standard](https://durgical.com/en/epidemiology/reference-standard/); needed for species identification and drug-susceptibility testing (DST). DST: molecular (rifampicin, isoniazid; then [fluoroquinolones](https://durgical.com/en/pharmacology/classes/fluoroquinolones/) and second-line drugs if resistance is found) and phenotypic from culture; targeted sequencing can test many drugs at once. Urine LF-LAM: point-of-care test for people with HIV, especially inpatients and those with low CD4. HIV test for everyone with TB. Histopathology of tissue (caseating granulomas) supports but does not prove TB; tissue is also sent for culture and molecular testing. [Adenosine deaminase (ADA)](https://durgical.com/en/biochemistry/enzymes/adenosine-deaminase/) helps in pleural and other serous fluids. TST and IGRA are not tests for active TB.

**Imaging**
[Chest](https://durgical.com/en/anatomy/region/chest/) X-ray for every respiratory symptomatic. Reactivation TB: upper-lobe and apical-segment opacities and [cavities](https://durgical.com/en/conditions/dental-caries/). Primary TB (children, HIV): hilar or mediastinal nodes, middle or lower lobe consolidation and effusion. Miliary TB: countless millet-sized nodules. CT is more sensitive in immunosuppressed people, transplant recipients, children and unclear X-rays. Ultrasound, CT or MRI guide the search and the biopsy in extrapulmonary disease.

## Differential diagnosis

- Bacterial pneumonia and [lung abscess](https://durgical.com/en/conditions/lung-abscess/)
- [Lung cancer](https://durgical.com/en/conditions/lung-cancer/)
- Nontuberculous [mycobacteria](https://durgical.com/en/microbiology/groups/mycobacteria/) (acid-fast on smear but negative on TB-specific molecular tests)
- Endemic mycoses such as [histoplasmosis](https://durgical.com/en/conditions/histoplasmosis/) and [paracoccidioidomycosis](https://durgical.com/en/conditions/paracoccidioidomycosis/)
- [Sarcoidosis](https://durgical.com/en/conditions/sarcoidosis/) (non-caseating granulomas)

## Which TB test does what

| Test | Detects | Strength | Weakness | Best use |
| --- | --- | --- | --- | --- |
| Rapid molecular test (Xpert MTB/RIF Ultra) | M. tuberculosis DNA and rifampicin-resistance mutations | Sensitive, about two hours, resistance at once | Detects dead bacilli: stays positive after past TB; not for follow-up | First test for every presumptive TB case |
| Sputum smear | Acid-fast bacilli | Cheap, fast, shows how infectious the patient is | Needs thousands of bacilli; cannot separate TB from NTM; no resistance data | Monitoring treatment response |
| Culture (liquid medium) | Live mycobacteria | Reference standard; species and full DST | Weeks to result; needs a biosafety laboratory | Confirmation, drug susceptibility, follow-up of resistant TB |
| [Urine LF-LAM](https://durgical.com/en/conditions/tb-hiv-coinfection/) | Lipoarabinomannan in urine | Bedside, no sputum needed, best in very low CD4 | Low sensitivity in people without advanced HIV | Seriously ill people with HIV |
| Chest X-ray or CT | Pattern of lung damage | Screens, shows extent and complications | Not specific: cancer, fungi and pneumonia look alike | Screening and staging; never proof alone |

## Goal of treatment

Confirm the diagnosis bacteriologically whenever possible and know the resistance pattern before or as treatment begins, so that every person starts an effective regimen.

## Treatment

**Medical**
Results guide treatment: rifampicin-susceptible TB is treated with the first-line regimen of the national programme; rifampicin resistance detected by the molecular test triggers testing for other drugs and [referral](https://durgical.com/en/family-medicine/referral-and-counter-referral-from-the-doctor-s-side/) for a drug-resistant regimen.

**Follow-up**
Treatment response is followed with smear and culture, not with the molecular test, because DNA from dead bacilli can keep it positive; a positive culture late in treatment suggests failure or resistance.

**Procedure**
Specimens are collected with [airborne precautions](https://durgical.com/en/nursing/transmission-based-precautions-contact-droplet-and-airborne/) (well-ventilated area, the patient wearing a surgical mask between samples); biopsies for culture travel in saline, and for histology in formalin.

## Complications

- Delayed diagnosis from relying on smear alone, with ongoing transmission
- Missed drug resistance when no DST is done
- Unnecessary TB treatment when imaging is treated as proof
- Misreading a positive molecular test in a person treated in the past

## Common traps

- **A negative smear rules out TB**: smear needs thousands of bacilli per millilitre and misses about half of cases, more in HIV and children; a molecular test and culture are needed
- **A positive molecular test after a previous episode means relapse**: Xpert detects DNA from dead bacilli; in previously treated people a positive result needs culture confirmation
- **Acid-fast bacilli on smear are always TB**: nontuberculous mycobacteria look the same; a TB-specific molecular test or culture identification settles it
- **TST or IGRA can diagnose active TB**: they show infection only; they can be negative in active disease and positive in latent infection
- **Upper-lobe cavity on X-ray equals TB**: lung cancer, fungal infection and abscess cavitate too; the diagnosis needs the bacillus

## Prognosis

Early bacteriological diagnosis with resistance testing shortens infectiousness and improves cure, especially in drug-resistant TB and in people with HIV.

## Prevention

- Active case finding: asking every patient, visitor and health worker about cough for more than 15 days
- Testing all household contacts of a TB case
- Systematic TB screening at every visit for people with HIV

## Test yourself

Think of the answer, then tap the question to see it.

## Which single test now comes first for a respiratory symptomatic in Colombia, and why?

A rapid molecular test such as Xpert MTB/RIF Ultra: more sensitive than smear and it reports rifampicin resistance in about two hours.

## Why is the molecular test not used to monitor treatment?

It detects DNA, which persists from dead bacilli, so it can stay positive in a patient who is improving; smear and culture show live bacilli.

## A 32-year-old man with HIV, CD4 40 cells/µL, is admitted with fever and weight loss; he cannot produce sputum. Which bedside test helps?

Urine LF-LAM, which is most sensitive in seriously ill people with very low CD4; a positive result supports starting TB treatment while culture is pending.

## Culture is slow. Why is it still requested?

It is the reference standard, identifies the species and allows drug-susceptibility testing of every drug, including second-line ones.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/conditions/tuberculosis-diagnostics/)

## Why it happens

- [Coal workers' pneumoconiosis and silicosis](https://durgical.com/en/general-pathology/coal-workers-pneumoconiosis-and-silicosis/)
- [Granulomatous pneumonia: tuberculosis and endemic fungi](https://durgical.com/en/general-pathology/granulomatous-pneumonia-tuberculosis-and-endemic-fungi/)
- [Granulomatous inflammation: caseating vs non-caseating, the causes to know](https://durgical.com/en/general-pathology/granulomatous-inflammation-caseating-vs-non-caseating-the-causes-to-know/)

## Connections

## In physiology 1

- [Innate and adaptive immunity: overview](https://durgical.com/en/physiology/innate-and-adaptive-immunity-overview/)

## Related conditions 11

- [Pulmonary tuberculosis](https://durgical.com/en/conditions/pulmonary-tuberculosis/)
- [Tuberculosis](https://durgical.com/en/conditions/tuberculosis/)
- [Latent tuberculosis infection](https://durgical.com/en/conditions/latent-tuberculosis-infection/)
- [Extrapulmonary tuberculosis](https://durgical.com/en/conditions/extrapulmonary-tuberculosis/)
- [TB/HIV coinfection](https://durgical.com/en/conditions/tb-hiv-coinfection/)
- [Spinal tuberculosis (Pott disease)](https://durgical.com/en/conditions/spinal-tuberculosis/)
- [Nontuberculous mycobacterial infections (MAC, M. abscessus, Buruli ulcer)](https://durgical.com/en/conditions/nontuberculous-mycobacterial-infections/)
- [Community-acquired pneumonia](https://durgical.com/en/conditions/community-acquired-pneumonia/)
- [Lung cancer](https://durgical.com/en/conditions/lung-cancer/)
- [Histoplasmosis](https://durgical.com/en/conditions/histoplasmosis/)
- [HIV infection and AIDS](https://durgical.com/en/conditions/hiv-infection-and-aids/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [Tuberculosis Overview](https://www.ncbi.nlm.nih.gov/books/NBK441916/) (StatPearls (NCBI Bookshelf), 2024); [Acid Fast Bacteria](https://www.ncbi.nlm.nih.gov/books/NBK537121/) (StatPearls (NCBI Bookshelf), 2023); [Clinical Testing and Diagnosis for Tuberculosis](https://www.cdc.gov/tb/hcp/testing-diagnosis/index.html) (Centers for Disease Control and Prevention (CDC), 2025); [WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed](https://www.who.int/publications/i/item/9789240089488) (World Health Organization, 2024); [Resolución 227 de 2020: lineamientos técnicos y operativos del Programa Nacional de Prevención y Control de la Tuberculosis](https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-227-de-2020.pdf) (Ministerio de Salud y Protección Social (Colombia), 2020); [Lineamiento para la implementación de los algoritmos diagnósticos de tuberculosis](https://www.ins.gov.co/BibliotecaDigital/lineamiento-para-la-implementacion-de-los-algoritmos-diagnosticos-de-tuberculosis.pdf) (Instituto Nacional de Salud (Colombia), 2022).

[← All conditions](https://durgical.com/en/conditions/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/conditions/tuberculosis-diagnostics/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/conditions/tuberculosis-diagnostics/
